Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Semaglutide (Ozempic/Wegovy): The FDA-Approved GLP-1 Standard Semaglutide is the original mainstream GLP-1 for weight loss, approved by the FDA as Ozempic for type 2 diabetes in 2017 and as Wegovy for chronic weight management in 2021
doi: 10.1038/302716a0 88 HolstJJOrskovCNielsenOVSchwartzTW
Annu Rev Genet 1995
GLP-1 receptor agonists approved for use in the UK include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia)
US$ 21.72
US$ 29.40
US$ 22.30
US$ 20.05
